Iwicki Mark T — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Iwicki Mark T has filed 1 SEC Form 4 filing across 1 company in the last 90 days.

Profile

Mark T. Iwicki is a biotechnology executive known for his role as Chief Executive Officer at Merus N.V., a clinical-stage immuno-oncology company. He has also held leadership positions at various biotech firms, contributing to the development of innovative therapeutics.

Board memberships

• Merus N.V.
• Third Harmonic Bio, Inc.
• Inhibikase Therapeutics, Inc.
• Akero Therapeutics, Inc.
• Q32 Bio Inc.

Awards & honors

• Leadership in immuno-oncology
• Development of bispecific antibody therapeutics
• CEO of multiple biotech firms

Recent Transactions

Companies — Last 90 Days

• Q32 Bio Inc. (QTTB) — 1 filings, last 2026-06-16

Frequently Asked Questions

Who is Iwicki Mark T?

Mark T. Iwicki is a biotechnology executive known for his role as Chief Executive Officer at Merus N.V., a clinical-stage immuno-oncology company. He has also held leadership positions at various biotech firms, contributing to the development of innovative therapeutics.…

How many SEC Form 4 filings has Iwicki Mark T submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of Iwicki Mark T's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week